Donald Trump is ending a Medicare Part D subsidy after 2026, which could leave some seniors paying higher prescription drug plan premiums starting in 2027.

Medicare Part D changes, premium stabilization expiration, and a Bridge demonstration converge with rising GLP-1 demand and costs. Medicare Part D plans are running out of easy ways to absorb the cost ...

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...

The Centers for Medicare & Medicaid Services (CMS) recently orchestrated a $5 billion election-year rescue operation for Democrats to hide the true costs of the Biden-Harris administration's Inflation ...

By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

After widespread criticism from healthcare providers, drug companies, and lawmakers, CMS has announced that it will not go forward with its proposed Medicare Part B payment program. The experimental ...

The Part D Premium Stabilization Demonstration will expire after 2026, the CMS announced Tuesday.